The Occurrence and Risk Assessment of Aflatoxin M1 in Yoghurt Samples from Hamadan, Iran

All published articles of this journal are available on ScienceDirect.

RESEARCH ARTICLE

The Occurrence and Risk Assessment of Aflatoxin M1 in Yoghurt Samples from Hamadan, Iran

Ali Heshmati1 iD Amir Sasan Mozaffari Mozaffari Nejad2 , * Open Modal iD Tayebeh Ghyasvand1
Authors Info & Affiliations
The Open Public Health Journal • 22 Sep 2020 • RESEARCH ARTICLE • DOI: 10.2174/1874944502013010512

Abstract

Background:

Aflatoxin M1 (AFM1) is a hepatocarcinogenic and hydroxylated metabolite of aflatoxin B1, detected in milk and milk products.

Objectives:

The aim of our research was to determine the incidence and risk assessment of AFM1 through the consumption of yoghurt in Hamadan province of Iran.

Methods:

Fifty yoghurt samples were gathered from various areas of Hamadan province, Iran and tested for AFM1 by ELISA technique. The estimated daily intake (EDI) and the liver cancer incidence of aflatoxin M1 were determined.

Results:

AFM1 was detected in 43 (86%) samples, (mean: 28.56 ng/kg; range: <5-98.65 ng/kg). The level of AFM1 in 9 (18%) samples was above the maximum tolerance limit (50 ng/kg). The AFM1 intake through yoghurt consumption in various population groups ranged from 0.016 to 0.032 ng/kg bw/day in mean consumers and 0.019 to 0.046 ng/kg bw/day in high consumers.

Conclusion:

The AFM1 intake through yoghurt contributed a slight part from the overall incidence of liver cancer in the Iranian population. From the findings of the current study, it can be derived that although the high percentage of yoghurt samples in Iran proved to be contaminated with AFM1 contents, did not show a public health concern considering the European Commission (EC) and the Institute of Standards and Industrial Research of Iran (ISIRI) maximum limits.

Keywords: Aflatoxin M1, Yoghurt, ELISA, Hamadan, Risk assessment, European commission.

1. INTRODUCTION

Yoghurt is one of the most important and popular products among fermented dairy products, which has been used as food consumed by the world population for thousands of years. Yoghurt contains nearly all nutrients necessary to sustain life [1, 2]. Also, it is a rich source of dietary minerals including vitamins (B6 and B12), calcium (Ca), magnesium (Mg), zinc (Zn), phosphorus (P), and potassium (K), and so many others [3]. It is also a great source of essential amino acids of great biological modality, generally including premier protein levels toward milk. Nevertheless, on the useful effects of yoghurt consumption, a substantial number of studies have presented the presence of heavy metals and aflatoxin M1 in foodstuff, which is a subject of serious concern, which has been increasing over the last few years [3].

Aflatoxin M1 (AFM1) is one of the groups of mycotoxin produced by Aspergillus species, especially A. nomius, A. flavus and A. parasiticus and found in contaminated milk (breast and animal), and dairy products. Researchers have demonstrated that the concentration of AFM1 is a dangerous toxic and carcinogenic for humans and animals [4-8].

Many countries have implemented regulations to control the amount of mycotoxins groups among food and agricultural products, especially for AFM1 in milk products. These regulations differ among several countries with respect to their economic considerations [4, 7, 9-12]. Hence, the European Commission (EC) and the Institute of Standards and Industrial Research of Iran (ISIRI) have set a limit of 50 ng/kg for AFM1 in yoghurt varieties.

The immediate detection of contamination is one of the beneficial methods to control aflatoxin M1 [13]. The current detection methods such as enzyme-linked immunosorbent assay (ELISA), high-performance liquid chromatography (HPLC), and thin-layer chromatography (TLC) are generally performed for the AFM1 analysis [4-8, 11-14]. In Iran, the ELISA technique is the most usual and popular among researchers because it is an ordinary, rapid, and low-cost technique for the survey of AFM1 [4-8, 15].

The aim of the current survey was to evaluate the occurrence and risk assessment of exposure of AFM1 through the consumption of yoghurt in the Hamadan province of Iran.

2. MATERIALS AND METHODS

2.1. Sample Collection

The current research is a cross-sectional study. For this purpose, 50 yoghurt samples were randomly purchased from supermarkets located in popular markets in different parts of Hamadan province, Iran, from October 2017 to August 2018. Eventually, all samples were carried to the lab and kept in the refrigerator at 4 oC. All samples were analyzed for AFM1 before the expiration date of the samples. All procedures of study were approved by the Ethics Committee of Hamadan University of Medical Sciences with No. IR.UMSHA.REC.1396.617.

2.2. Methods

The quantitative measurement of AFM1 in samples was distinguished by competitive ELISA using AFM1 test kit (RIDASCREEN® AFM1 Art. No.: R1121, R-Biopharm, Darmstadt, Germany). The preparation of the yoghurt samples and AFM1 measurement were performed according to the method described by the kit manufacturer. The mean lower limit of detection (LOD) for AFM1 in yoghurt was 5 ng/kg.

2.3. Risk Assessment for Exposure to AFM1 Through Yoghurt

The risk of AFM1 intake through yoghurt was carried out by the deterministic approach and calculated according to the following equation [16, 17]:

AFM1 intake (ng/kg bw/day) = the concentration of AFM1 in yoghurt (ng/kg) × 95th percentile (for high consumers) or mean (for mean consumers) of per capita yoghurt consumption (kg)/ body weight (kg) Equation 1.

95th percentile (for high consumers) or mean (for mean consumers) of per capital yoghurt consumption was obtained by food frequency questionnaires (FFQ), Before the study, FFQ was prepared and given to people with different age-sex groups to complete it during a month. The people were randomly selected. For all participants in FFQ study, written informed consent was obtained.

For risk assessment, AFM1 value in yoghurt samples in which the concentration of this mycotoxin was lower than LOD was considered as LOD [17].

The liver cancer incidence due to AFM1 consumption was estimated according to Equation 2 [17]:

Liver cancer incidence (cancers/yr/108 persons) = AFM1 intake (ng/kg bw/day) × potency

Potency= 0.001 × (1-P) + 0.03 × P

In these equations, the liver cancer potency of AFM1 in individuals positive for negative hepatitis B surface antigen (HBsAgz +) and individuals negative for negative hepatitis B surface antigen (HBsAgz -) was considered as 0.03 and 0.001 cancers/year/ ng of AFM1/ kg body weight/ day in a population of 100,000 [17]. According to previous studies, HBsAgz + prevalence rate in Iran was 1.7% [18].

2.4. Statistical Analysis

The concentrations of AFM1 in milk samples were analyzed by SPSS Statistics 16.0 for Windows. One-side t-test was applied to compare the mean concentration of AFM1 samples with the maximum acceptable amount of the ISIRI and European Union (50 ng/kg) regulation. Differences between values were considered significant at P ≤ 0.05.

3. RESULTS

The occurrence and levels of AFM1 in yoghurt samples consumed in Hamadan province are presented in Table 1. AFM1 was detected above an acceptable level of 86% (43/50) in the analyzed samples, ranging from <5 to 98.65 ng/kg. Levels of the AFM1 in 9 (18%) yoghurt samples exceeded the ISIRI and European union i.e. 50 ng/kg. On the other hand, considering the US FDA [19] limits for AFM1 in milk (500 ng/l), none of the samples had levels above the maximum tolerance limit.

The AFM1 intakes through yoghurt in different age-sex groups of Iran population are shown in Table 2. The mean AFM1 intake in various population groups ranged from 0.016 to 0.032 ng/kg bw/day in mean consumers and 0.019 to 0.046 ng/kg bw/day in high consumers. Data regarding the potential liver cancer risk of AFM1 in yoghurt in the Iranian population were estimated and presented in Table 2.



Table 1.
The occurrence of AFM1 in yoghurt samples from Hamadan (Iran) market.
Sample type N Positive Mean (ng/kg) Standard Deviation (ng/kg) No. of Positive Samples with AFM1 Range (ng/kg)
<5 ng/kg 5-50 ng/kg >50 ng/kg
Yoghurt 50 43 (86%) 28.56 26.39 7 (14%) 34 (68%) 9 (18%) <5-98.65
Table 2.
Exposure assessment for AFM1 intake in different sex-age groups of Iran population through yoghurt consumption using deterministic method.
Group and Sex No. of Consumers Mean Weight
(kg) 		Mean Consumers High Consumers (percentile 95)
Yoghurt intake (kg/day) AFM1 intake (ng/kg bw/day) Estimation of cancer risk (cancers/yr/108 persons) Yoghurt intake (kg/day) AFM1 intake (ng/kg bw/day) Estimation of cancer risk (cancers/yr/108 persons)
Infant (4-9 years)
Male 56 27.56 0.025 0.026 0.039 0.034 0.036 0.054
Female 68 25.12 0.027 0.032 0.048 0.040 0.046 0.069
Teenagers (10-19 years)
Male 85 52.16 0.034 0.019 0.028 0.042 0.024 0.035
Female 68 48.15 0.037 0.023 0.034 0.045 0.028 0.041
Adults (20-65 years)
Male 95 78.65 0.042 0.016 0.023 0.051 0.019 0.028
Female 89 64.25 0.045 0.020 0.030 0.054 0.024 0.036
Elderly (>65 years)
Male 45 71.25 0.045 0.018 0.027 0.055 0.023 0.034
Female 53 59.36 0.046 0.023 0.034 0.058 0.029 0.043
Table 3.
The occurrence and levels of aflatoxin M1 (ng/kg) in various yoghurt samples published in previous studies.
Location No. of Samples No. Positive Samples (%) Detection Method Mean (ng/kg) Range (ng/kg) Exceeded Regulation, n (%) Reference
Iran 61 30 (49.2) TLC 26 15 – 102 10 (16.4) Fallah et al. [34]
Turkey 80 70 (87.5) ELISA 66.1 10 – 475 16 (20) Atasever et al. [28]
Iran 60 59 (98.33) ELISA 51.66 6.2 – 87 38 (63.33) Issazadeh et al. [35]
Turkey 26 26 (100) ELISA 238 125 – 269 26 (100) Tosun et al. [27]
Pakistan 96 59 (61) HPLC 90.4 4 – 615.8 28 (47) Iqbal et al. [34]
Pakistan 96 32 (33.33 ) HPLC 90.4 LOD – 880 21 (21.87) Iqbal et al. [37]
Turkey 50 50 (100) ELISA 55.28 40.62 – 72.04 5 (10) Temamogullari & Kanici [38]
Iran 60 48 (80) ELISA 130.5 19.7 – 319.4 3 (5) Rahimi [39]
Iran (Traditional) 40 40 (100) ELISA 33.6 6 – 91 1 (2.5) Mason et al. [25]
Iran 42 10 (23.8) ELISA 15.1 6.3 – 21.3 0 Bahrami et al. [40]
South Korea 55 15 (27.27) HPLC 51* 20 – 150 NR Kim-Soo et al. [41]
Malaysia 5 2 (40) ELISA 16.45* 7.5 – 31 0 Nadira et al. [42]
Pakistan 66 26 (39.39) HPLC 56 LOD – 196.3 8 (12.12) Iqbal et al. [43]
Qatar 21 16 (76.1) ELISA 31.32 4.16-38.21 0 Hassan et al. [44]
Kenya 38 NR ELISA 117 17 – 1100 25 (65.78 ) Lindahl et al. [45]
China 27 15 (55.5) ELISA 17.2 4 – 47 0 Guo et al. [46]
*Mean of positive samples; NR: Not reporte

4. DISCUSSION

Yoghurt is a favorite fermented dairy product, which is used as part of the popular diet in Iran because yoghurt is useful to affect human’s health and has nutritional value. Various types of fermented dairy products have been made and consumed in individual households in Iran, Turkey, Qatar, Lebanon, and other Middle Eastern countries for centuries.

Considering the present findings, we detected a high level of AFM1 contamination in yoghurt samples from Iran. In a prior survey, Cano-Sancho et al. [16] reported the lower level of AFM1 at a detectable level in yoghurt samples; but in a recent study, Altun et al. [20] detected AFM1 in 100% of yoghurt samples. Various studies by other researchers from different countries have previously been conducted on high or low contamination levels of AFM1 in yoghurt. Table 3 shows the compilation of data level of AFM1 contamination in yoghurt samples from previous studies from several countries measured by different techniques including HPLC and ELISA.

Hassan and Kassaift [21] from Lebanon using ELISA method reported that 49 (72%) of 68 samples of yoghurt were detected with AFM1 and in 9 (14%) samples, the amount of AFM1 was higher than the EU regulations (50 ng/kg), this result is approximately similar to our research results. The other survey from Iran by Tavakoli et al [7] that were done with ELISA technique on 50 samples of yoghurt, 35 (70%) of samples were contaminated with AFM1. Also, 6 (17.4%) samples of yoghurt had greater AFM1 content than the limit allowed in European Union (EU) 50 (ng/kg).

The other obtained results reported by Tabari et al. [22] determined AFM1 levels in 120 yoghurt samples from Guilan province in Iran using the ELISA method. They have reported that 100% of the samples found aflatoxin M1 by a mean concentration of 28.2 ng/kg. Also, 16 (13.3%) samples were above the permissible quantity according to the EC (50 ng/kg). However, this result is in contrast to our findings, that showed 86% (43/50) were contaminated with AFM1.The other conducted results were revealed in Serbia by Tomašević et al. [23], which were observed with ELISA, from 56 samples of yoghurt, all samples (100%) were contaminated with AFM1. Also, 22 (39.2%) samples were above the permissible level according to the EC (50 ng/kg). But, our results reported that approximately some of the yoghurt samples were contaminated with AFM1. This result from Serbia is similar to another study from Iran by Nikbakht et al. [24]. They detected that all yoghurt samples (100%) were contaminated with AFM1; and also, 20 (22.22%) of the samples were above the permissible level according to EU (50 ng/kg).

In a previous study performed in Iran, Mason et al. [25] revealed that in 37 (92.5%)out of 40 industrial yoghurt samples, aflatoxin M1 was detected in concentration between <5 and 71 ng/kg; and in 3 (7.5%) samples, the contamination level exceeded the maximum permissible limit (50 ng/kg). In agreement with our research, these reports proved a widespread incidence of aflatoxin M1 in yoghurt samples ready and consumed in Iran. Compared to some reports from several countries, our results showed higher contamination. In Turkey, for example, aflatoxin M1 was detected in 2 (3.3%) out of 60 yoghurt samples with a range of 24 to 28 ng/kg. Also, none of the samples had aflatoxin M1 above the maximum tolerance limit (50 ng/kg) set by the EU [26]. In another survey from China using the ELISA method [17], it was observed that in 8 (4.49%), out of 178 samples, aflatoxin M1 was present. The contamination level was detected in 8 (4.49%) of the samples which were above 50 ng/kg according to the EU.

According to several studies carried out in different neighboring countries of Iran, Turkey Altun et al. [20]; Tosun & Ayyildiz [27]; Atasever et al. [28] detected a high incidence of aflatoxin M1 in yoghurt samples (100%, 100% and 87.5%, respectively). These results were detected by the ELISA method.

As seen in Table 3, the contamination levels of aflatoxin M1 in yoghurt samples vary from one study to another. This variability can be explained by different factors such as geographical region, yoghurt-making procedures, analytical method employed and seasons variability [4, 29]. On the other hand, the previous study by Iha et al. [30] showed that the process of fermentation of yoghurt has no effect on aflatoxin M1. Also, the other surveys revealed that the quality of raw materials in yoghurt is effective on the presence and levels of AFM1. It is also noted that little or no reduction in aflatoxin M1 levels occurs as a result of pasteurization [31].

The incidence of liver cancer in Iran was 3.53 cancers per year per 105 persons or 3530 cancers/yr/108 persons [32] and AFM1 intake through yoghurt contributed 0.023-0.048 cancers/yr/108 person for mean consumers and 0.028-0.069 cancers/yr/108 person for high consumers. Therefore, our findings indicated AFM1 in yoghurt contributed a slight part from the overall incidence of liver cancer in the Iranian population. The intake of AFM1 and liver cancer incidence due to the consumption of this mycotoxin through yoghurt and milk was reported in other countries including China, Spain, Greece and Serbia [16, 17, 33]. The range of liver cancer incidence or hepatocellular carcinoma (HCC) due to AFM1 intake through milk and yoghurt was 0.025–0.033 case or cancers/yr/108 person in China that it was similar to our study while in Serbia and Greece was 3.6–0.4.7 and 0.7–0.9 case or cancers/yr/108 person, respectively that it was higher than the current study [17, 33]. The dispenses were related to the AFM1 level and consumption value of yoghurt.

CONCLUSION

From our findings of the current study, it can be derived that although a high percentage of yoghurt samples in Iran proved to have AFM1 contents, but it does not show a public health concern considering the European Commission (EC) and the Institute of Standards and Industrial Research of Iran (ISIRI) maximum limits. However, regarding the important role of milk, especially dairy products in the human diet, there is a huge concern about the presence of AFM1 in milk and dairy products. Hence, it is important to use fast methods in the detection of AFM1 in milk and dairy products; and also, the Iranian public health authorities have to monitor ceaselessly to detect AFM1 contamination.

AUTHORS’ CONTRIBUTIONS

Ali Heshmati, and Amir Sasan Mozaffari Nejad conceived, designed, analyzed, and interpreted the data; Tayebeh Ghyasvand and Amir Sasan Mozaffari Nejad performed data collection. Ali Heshmati and Amir Sasan Mozaffari Nejad wrote the first draft and finalized it. All authors read and approved the final manuscript.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

All procedures of the study were approved by the Ethics Committee of Hamadan University of Medical Sciences, Iran with No. IR.UMSHA.REC.1396.617.

HUMAN AND ANIMAL RIGHTS

Not applicable.

CONSENT FOR PUBLICATION

Not applicable.

AVAILABILITY OF DATA AND MATERIALS

The data that support the findings of this study are with the corresponding author, [ASMN], and can be made available on reasonable request.

FUNDING

The authors appreciate the Vice-Chancellor of Research and Technology of Hamadan University of Medical Sciences for financial support (Project No. 9609286051).

CONFLICT OF INTEREST

The authors declare no conflicts of interest, financial or otherwise.

ACKNOWLEDGEMENTS

Declared none.

REFERENCES

1
Czaja T, Baranowska M, Mazurek S, Szostak R. Determination of nutritional parameters of yoghurts by FT Raman spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc 2018; 196: 413-7.
2
Pothuraju R, Yenuganti VR, Hussain SA, Sharma M. Fermented Milk in Protection Against Inflammatory Mechanisms in Obesity Immunity and Inflammation in Health and Disease 2018; 389-401.
3
Cano-Sancho G, Perelló G, Nadal M, Domingo J. Comparison of the nutritional composition and the concentrations of various contaminants in branded and private label yogurts. J Food Compos Anal 2015; 42: 71-7.
4
Kamkar A, Fallah AA, Mozaffari Nejad AS. The review of aflatoxin M1 contamination in milk and dairy products produced in Iran. Toxin Rev 2014; 33(4): 160-8.
5
Kamkar A, Yazdankhah S, Nafchi AM, Nejad AS. Aflatoxin M1 in raw cow and buffalo milk in Shush city of Iran. Food Addit Contam Part B Surveill 2014; 7(1): 21-4.
6
Mashak Z, Jafari Sohi H, Heshmati A, Mozaffari Nejad AS. Assessment of AflatoxinM1 Contamination in UHT Flavored Milk Samples in Karaj, Iran. Iran J Pharm Res 2016; 15(3): 407-11.
7
Tavakoli H, Kamkar A, Riazipour M, Mozaffari Nejad AS, Rafati H. Assessment of aflatoxin M1 levels by enzyme-linked immunosorbent assay in yoghurt consumed in Tehran, Iran. Asian J Chem 2013; 25(5): 2836-8.
8
Nejad ASM, Heshmati A, Ghiasvand T. The occurrence and risk assessment of exposure to aflatoxin M1 in ultra-high temperature and pasteurized milk in Hamadan province of Iran. Osong Public Health Res Perspect 2019; 10(4): 228-33.
9
Heshmati A, Mozaffari Nejad AS. Ochratoxin A in dried grapes in Hamadan province, Iran. Food Addit Contam Part B Surveill 2015; 8(4): 255-9.
10
Khodadadi M, Malekpour A, Mehrgardi MA. Aptamer functionalized magnetic nanoparticles for effective extraction of ultratrace amounts of aflatoxin M1 prior its determination by HPLC. J Chromatogr A 2018; 1564: 85-93.
11
Mozaffari Nejad AS, Bayat M, Ahmadi AA. Investigation of Aflatoxin B-1 in Spices Marketed in Hyderabad, India by ELISA Method. J Pure Appl Microbiol 2013; 7(4): 3219-23.
12
Mozaffari Nejad AS, Giri A. The measurement of Aflatoxin B1 in chilli and black peppers of qaemshahr, Iran. J Kerman Univ Med Sci 2015; 22(2): 185-93.
13
Ben Aissa S, Mars A, Catanante G, Marty J-L, Raouafi N. Design of a redox-active surface for ultrasensitive redox capacitive aptasensing of aflatoxin M1 in milk. Talanta 2019; 195: 525-32.
14
Mozaffari Nejad AS, Sabouri Ghannad M, Kamkar A. Determination of aflatoxin B1 levels in Iranian and Indian spices by ELISA method. Toxin Rev 2014; 33(4): 151-4.
15
Moosavy M, Roostaee N, Katiraee F, Habibi-Asl B, Mostafavi H, et al. Aflatoxin M1 occurrence in pasteurized milk from various dairy factories in Iran. Int Food Res J 2013; 20(6): 3351.
16
Cano-Sancho G, Marin S, Ramos AJ, Peris-Vicente J, Sanchis V. Occurrence of aflatoxin M1 and exposure assessment in Catalonia (Spain). Rev Iberoam Micol 2010; 27(3): 130-5.
17
Guo Y, Yuan Y, Yue T. Aflatoxin m1 in milk products in china and dietary risk assessment. J Food Prot 2013; 76(5): 849-53.
18
Porolajal J, Majdzadeh R. Prevalence of chronic Hepatitis B infection in Iran. Majallah-i Ipidimiyuluzhi-i Iran 2009; 4(3): 1-8.
19
FDA S. 527. 400 Whole Milk, Low Fat Milk, Skim Milk–Aflatoxin M1 (CPG 710610) FDA/ORA Compliance Policy Guides 2005.
20
Altun SK, Temamoǧullari FK, Atasever M, Demirci M. Determination of Aflatoxin M1 levels in some cheese types and retail yoghurt samples. Res J Biotechnol 2017; 12(10): 47-52.
21
Hassan HF, Kassaify Z. The risks associated with aflatoxins M1 occurrence in Lebanese dairy products. Food Control 2014; 37: 68-72.
22
Tabari M, Tabari K, Tabari O. Aflatoxin M1 determination in yoghurt produced in Guilan province of Iran using immunoaffinity column and high-performance liquid chromatography. Toxicol Ind Health 2013; 29(1): 72-6.
23
Tomašević I, Petrović J, Jovetić M, et al. Two year survey on the occurrence and seasonal variation of aflatoxin M1 in milk and milk products in Serbia. Food Control 2015; 56: 64-70.
24
Nikbakht MR, Lachiniyan S, Rahbar S, et al. Aflatoxin M1 contamination in traditional yoghurts produced in Guilan province, Iran. Asian Journal of Pharmaceutical Research and Health Care 2016; 8(1)
25
Mason S, Arjmandtalab S, Hajimohammadi B, et al. Aflatoxin M1 contamination in industrial and traditional yogurts produced in Iran. Journal of food quality and hazards control 2015; 2(1): 11-4.
26
Sahin HZ, Celik M, Kotay S, Kabak B. Aflatoxins in dairy cow feed, raw milk and milk products from Turkey. Food Addit Contam Part B Surveill 2016; 9(2): 152-8.
27
Tosun H, Ayyıldız T. Occurrence of aflatoxin M1 in organic dairy products. Qual Assur Saf Crops Foods 2013; 5(3): 215-9.
28
Atasever MA, Atasever M. ÖZTURAN K. Aflatoxin M1 levels in retail yoghurt and ayran in Erzurum in Turkey. Turk J Vet Anim Sci 2011; 35(1): 59-62.
29
Fallah AA, Jafari T, Fallah A, Rahnama M. Determination of aflatoxin M1 levels in Iranian white and cream cheese. Food Chem Toxicol 2009; 47(8): 1872-5.
30
Iha MH, Barbosa CB, Okada IA, Trucksess MW. Aflatoxin M1 in milk and distribution and stability of aflatoxin M1 during production and storage of yoghurt and cheese. Food Control 2013; 29(1): 1-6.
31
Jasutiene I, Garmiene G, Kulikauskiene M. Pasteurisation and fermentation effects on Aflatoxin M1 stability. Milchwissenschaft 2006; 61(1): 75-9.
32
Fazli Z, Fatemeh S, Abdi A, Pourhosseingholi M, Taghinejad H. Studying of liver cancer mortality and morbidity burden in Iran. Sci J Ilam Univ Med Sci 2012; 4(20): 117-22.
33
Udovicki B, Djekic I, Kalogianni EP, Rajkovic A. Exposure assessment and risk characterization of Aflatoxin M1 intake through consumption of milk and yoghurt by student population in Serbia and Greece. Toxins (Basel) 2019; 11(4): 205.
34
Fallah AA, Rahnama M, Jafari T, Saei-Dehkordi SS. Seasonal variation of aflatoxin M1 contamination in industrial and traditional Iranian dairy products. Food Control 2011; 22(10): 1653-6.
35
Issazadeh K, Darsanaki R, Pahlaviani M. Occurrence of aflatoxin M1 levels in local yogurt samples in Gilan Province, Iran. Ann Biol Res 2012; 3(8): 3853-5.
36
Iqbal SZ, Asi MR. Assessment of aflatoxin M1 in milk and milk products from Punjab, Pakistan. Food Control 2013; 30(1): 235-9.
37
Iqbal SZ, Asi MR, Jinap S. Variation of aflatoxin M1 contamination in milk and milk products collected during winter and summer seasons. Food Control 2013; 34(2): 714-8.
38
Temamogullari F, Kanici A. Short communication: Aflatoxin M1 in dairy products sold in Şanlıurfa, Turkey. J Dairy Sci 2014; 97(1): 162-5.
39
Rahimi E. Survey of the occurrence of aflatoxin M1 in dairy products marketed in Iran. Toxicol Ind Health 2014; 30(8): 750-4.
40
Bahrami R, Shahbazi Y, Nikousefat Z. Aflatoxin M1 in milk and traditional dairy products from west part of Iran: Occurrence and seasonal variation with an emphasis on risk assessment of human exposure. Food Control 2016; 62: 250-6.
41
KiM–Soo KRLM. Aflatoxin M1 levels in dairy products from South Korea determined by high performance liquid chromatography with fluorescence detection. Journal of Food and Nutrition Research 2016; 55(2): 171-80.
42
Nadira AF, Rosita J, Norhaizan M, Redzwan SM. Screening of aflatoxin M1 occurrence in selected milk and dairy products in Terengganu, Malaysia. Food Control 2017; 73: 209-14.
43
Iqbal SZ, Asi MR, Malik N. The seasonal variation of aflatoxin M1 in milk and dairy products and assessment of dietary intake in Punjab, Pakistan. Food Control 2017; 79: 292-6.
44
Hassan ZU, Al-Thani R, Atia FA, Almeer S, Balmas V, et al. Evidence of low levels of aflatoxin M1 in milk and dairy products marketed in Qatar. Food Control 2018; 92: 25-9.
45
Lindahl JF, Kagera IN, Grace D. Aflatoxin M1 levels in different marketed milk products in Nairobi, Kenya. Mycotoxin Res 2018; 34(4): 289-95.
46
Guo L, Wang Y, Fei P, Liu J, Ren D. A survey on the aflatoxin M1 occurrence in raw milk and dairy products from water buffalo in South China. Food Control 2019; 105: 159-63.